Sharp Clinical Seeks Approval to Import Controlled Drugs
Published Date: 2/26/2025
Notice
Summary
Sharp Clinical Services, LLC wants to become an official importer of certain controlled substances. This means they’ll be allowed to bring in specific drugs that need special handling. If approved, this could affect companies and regulators keeping an eye on drug imports, with no immediate cost changes announced.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in